No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
RBC Capital Remains a Hold on Nevro Corp (NVRO)
Truist Financial Maintains Nevro(NVRO.US) With Hold Rating, Cuts Target Price to $4.7
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Mizuho Securities Maintains Nevro(NVRO.US) With Hold Rating, Announces Target Price $6
Here's Why You Should Retain Nevro Stock in Your Portfolio Now
Unlock the Full List